Anti-CD40 predominates over anti-CTLA-4 to provide enhanced antitumor response of DC-CIK cells in renal cell carcinoma
在肾细胞癌中,抗CD40抗体比抗CTLA-4抗体更能增强DC-CIK细胞的抗肿瘤反应。
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2022.925633
Zhang, Ying; Wu, Xiaolong; Sharma, Amit; Weiher, Hans; Schmid, Matthias; Kristiansen, Glen; Schmidt-Wolf, Ingo G H